arrow
C

Corrado Pelaia

University Magna Graecia of Catanzaro
H指数:40
被引数:4,847

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Sublingual allergen immunotherapy: evidence from randomized trials, real-world studies and meta-analyses

舌下过敏原免疫疗法:来自随机试验、真实世界研究和荟萃分析的证据

2026-09-150
OA
Artificial Intelligence Models for Mortality and Outcome Prediction in Intensive Care Unit Sepsis: A Systematic Review

重症监护室脓毒症患者死亡率和结局预测的人工智能模型:一项系统综述

2026-06-250
OA
Remission in Global Airway Diseases: EUFOREA Consensus Paper

全球气道疾病的缓解:EUFOREA共识文件

2026-06-160
OAAI
Phenotyping of Obstructive Sleep Apnea Syndrome and Association with Cognitive Impairment, a Real-Life Study

阻塞性睡眠呼吸暂停综合征表型分析及其与认知障碍的关联:一项真实世界研究

2026-05-240
OA
Preliminary Effects of Benralizumab in an AML Cell Model with Promyelocytic Features Expressing IL-5R: An Exploratory Proof-of-Concept Study

苯那利珠单抗在表达IL-5R且具有早幼粒细胞特征的AML细胞模型中的初步效果:一项探索性概念验证研究

2026-03-130
OA
Mucosal Remodeling in Chronic Rhinosinusitis with Nasal Polyps: The Role of Innate Lymphoid Cells and Reprogramming Under IL-4Rα Blockade

慢性鼻窦炎伴鼻息肉的黏膜重塑:固有淋巴细胞的角色及在IL-4Rα阻断下的重编程

2026-02-260
OAAI
Echocardiographic effects of dupilumab in patients with severe type 2 asthma

dupilumab对严重2型哮喘患者的超声心动图影响

2026-01-190
OAAI
Sex-Based Comparison of Remission in Patients with Severe Type 2 Asthma Treated with Biologics: A Real-World Analysis from the "Southern Italy Network on Severe Asthma Therapy"

性别对接受生物制剂治疗的严重2型哮喘患者缓解情况的比较:来自“意大利南部严重哮喘治疗网络”的真实世界分析

2026-01-010
PRE